Azienda Ospedaliera V. Cervello   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Palermo Italy (1909)

Organization Overview

First Clinical Trial
2000
NCT00733811
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

beta-Thalassemia (Phase 4)

Hemoglobinopathies (Phase 4)

Hepatitis, Chronic (Phase 3)

Osteoporosis (Phase 2)

Thalassemia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 5